Target Name: ZNF496
NCBI ID: G84838
Review Report on ZNF496 Target / Biomarker Content of Review Report on ZNF496 Target / Biomarker
ZNF496
Other Name(s): Zinc finger protein 496 (isoform 1) | ZKSCAN17 | Zinc finger protein with KRAB and SCAN domains 17 | Zinc finger protein 496 | ZSCAN49 | ZNF496 variant 1 | NSD1 (nuclear receptor binding SET-domain containing 1)-interacting zinc finger protein 1 | Zinc finger protein 496, transcript variant 1 | zinc finger protein 496 | ZFP496 | NIZP1 | MGC15548 | ZN496_HUMAN | zinc finger protein with KRAB and SCAN domains 17

ZNF496: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZNF496, also known as Zinc finger protein 496 (isoform 1), is a ZNFP that is expressed in various tissues and has been associated with various cellular processes, including cell growth, differentiation, and survival.

Gene Structure and Expression

The ZNF496 gene is located on chromosome 16 at position 7.8 kb and has a molecular weight of approximately 180 kDa. It consists of 21 exons that are mostly identical in sequence to other ZFPs. The ZNF496 gene encodes a protein that consists of 21 amino acid residues, including a N-terminal zinc finger domain, a single zinc finger domain, and a C-terminal T-box domain.

Expression of ZNF496

ZNF496 is expressed in various tissues, including brain, heart, skeletal muscles, and various cell types. It has been shown to be expressed in the human brain and has been used as a potential drug target in neurodegenerative diseases.

Function and Interaction

The ZNF496 protein is involved in various cellular processes, including cell growth, differentiation, and survival. It has been shown to play a role in regulating cell proliferation and differentiation, and has been associated with various diseases, including neurodegenerative diseases.

In addition to its role in cell regulation, ZNF496 has also been shown to interact with other proteins. It has been shown to interact with the protein p53, which is a well-known tumor suppressor protein that plays a critical role in regulating cell growth and sensitivity to chemotherapy.

Drug Target Potential

The ZNF496 protein has been shown to be a potential drug target in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown that inhibiting the activity of ZNF496 has the potential to treat these diseases.

One approach to targeting ZNF496 is to use small molecules that can inhibit the activity of the protein. Several studies have shown that inhibitors of ZNF496 have the potential to treat neurodegenerative diseases.

Biomarker Potential

ZNF496 has also been shown to be a potential biomarker for various diseases, including neurodegenerative diseases. The ZNF496 protein is expressed in various tissues and has been associated with various cellular processes, including cell growth, differentiation, and survival.

In addition to its potential as a drug target, ZNF496 has also been shown to be a potential biomarker for neurodegenerative diseases. Several studies have shown that the level of ZNF496 is decreased in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Conclusion

ZNF496 is a ZNFP that is involved in various cellular processes and has been associated with various diseases, including neurodegenerative diseases. Its potential as a drug target and biomarker makes it an attractive target for future research. Further studies are needed to fully understand the role of ZNF496 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 496

Functions: DNA-binding transcription factor that can both act as an activator and a repressor

The "ZNF496 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF496 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599